Radiodermatitis
Conditions
Interventions
This is a pilot, single-blind, single-arm clinical trial. Experimental group: 25 women aged between 24 and 70 years, diagnosed with breast cancer who were consulted at the “Radiotherapy Service of Con
D27.505.696.706.776
Sponsors
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Eligibility
Sex/Gender
Female
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women aged between 40 years and 70 years; with invasive breast cancer; with pathological staging I – TNM (tumor -T; lymph node - N; metastasis - M) stage T1N0, i.e., unifocal lesion measuring up to 2.0 cm without lymph node involvement through lymph node sampling from the axilla or sentinel lymph node research; patients with therapeutic plans that involve only breast treatment
Exclusion criteria
Exclusion criteria: Women with a history of collagenosis (rheumatological autoimmune diseases); patients with large breasts, that is, with the distance between the sternum and the mid-axillary line greater than 25 cm; patients with therapeutic plans that involve treatments of areas other than the breasts, such as axillary drainage, supraclavicular or internal mammary fossa drainage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Protection of the skin that will receive radiation is expected to be found, assessed by clinical examination, so that at most, the appearance of grade 1 radiodermatitis is observed. Data collected at the beginning and weekly, until the end of breast radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactMarli Gerenutti
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Outcome results
None listed